Virtual colonoscopy

Medical Services Advisory Committee
Record ID 32002000833
Authors' objectives:

This report aims to provide advice on the state of play of the introduction and use of virtual colonoscopy.

Authors' recommendations: Safety: Based on the available evidence, virtual colonoscopy (VC) appears to be safe when used for diagnosing colorecal cancer in individual patients. However, its safety as a population-based screening tool has yet to be evaluated. Training: Professional accreditation and/or training should be encouraged and endorsed by a professional body and might include one or more of the following: fifty VCs performed as a comparative study with conventional colonoscopy correlation, or fifty VC examinations performed under supervision of an accredited radiologist; - completion of an approved teaching package; - attendance at an approved teaching course or fellowship; - performance of a minimum annual number of VC examinations per year; and - development of competency in using the relevant hardware and software. Indications: VC appears to be an appropriate test in the following clinical situations which warrant full colonic evaluation: - rectal bleeding where conventional colonoscopy is contraindicated (eg anticoagulated patients or patients with severe comorbidity/ies); - patients who are unfit for sedation; - where a preceding conventional colonoscopy was incomplete or technically difficult; - non-traversable stricture due to diverticular disease or malignancy; - obstructed colon; - megacolon; and - fistulous disease. VC has not been adequately evaluated as a population-based screening test at this stage.
Authors' methods: Systematic review
Project Status: Completed
Year Published: 2002
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Colonography, Computed Tomographic
  • Colonoscopy
  • Colorectal Neoplasms
Organisation Name: Medical Services Advisory Committee
Contact Address: MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
Contact Email:
Copyright: Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.